Mammalian cell-produced therapeutic proteins: heterogeneity derived from protein degradation.

Mammalian cell-produced therapeutic proteins: heterogeneity derived from protein degradation.

Item
http://www.wikidata.org/entity/Q38239464
The future of host cell protein (HCP) identification during process development and manufacturing linked to a risk-based management for their control.Expression of a Human Prostatic Acid Phosphatase (PAP)-IgM Fc Fusion Protein in Plants Using In vitro Tissue Subculture.Studies to Prevent Degradation of Recombinant Fc-Fusion Protein Expressed in Mammalian Cell Line and Protein Characterization.Tryptophan oxidation catabolite, N-formylkynurenine, in photo degraded cell culture medium results in reduced cell culture performance.Cascading effect in bioprocessing-The impact of mild hypothermia on CHO cell behavior and host cell protein composition.Identification of multiple sources of the acidic charge variants in an IgG1 monoclonal antibody.Combination of temperature shift and hydrolysate addition regulates anti-IgE monoclonal antibody charge heterogeneity in Chinese hamster ovary cell fed-batch culture.Elucidating the effects of arginine and lysine on a monoclonal antibody C-terminal lysine variation in CHO cell cultures.
P2860

Mammalian cell-produced therapeutic proteins: heterogeneity derived from protein degradation.

Item
http://www.wikidata.org/entity/Q38239464
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Mammalian cell-produced therap ...... ived from protein degradation.
@en
type
label
Mammalian cell-produced therap ...... ived from protein degradation.
@en
prefLabel
Mammalian cell-produced therap ...... ived from protein degradation.
@en
P1433
P1476
P2093
P304
P31
P356
P478
P577
P5875
P698
P356
P1433
P1476
Mammalian cell-produced therap ...... ived from protein degradation.
@en
P2093
P304
P31
P356
10.1016/J.COPBIO.2014.07.007
P478
P577
P5875
P698